Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination

The coronavirus disease of 2019 (COVID-19) has been a cause of significant morbidity and mortality worldwide. Among the short- and long-term consequences of COVID-19, myocarditis is a disease to be taken into consideration. Myocarditis, in general, is related to a poor prognosis. However, the epidem...

Full description

Bibliographic Details
Main Authors: Ana I. Molina-Ramos, Elisabeth Gómez-Moyano, Jorge Rodríguez-Capitán, María Angullo-Gómez, Patricia Gallardo-Jiménez, Iván Pérez de Pedro, Lucía Valiente de Santis, Beatriz Pérez-Villardón, Isabel Piñero-Uribe, Javier Mora-Robles, Víctor Manuel Becerra-Muñoz, Manuel Jiménez-Navarro
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/23/6999
_version_ 1797462932387266560
author Ana I. Molina-Ramos
Elisabeth Gómez-Moyano
Jorge Rodríguez-Capitán
María Angullo-Gómez
Patricia Gallardo-Jiménez
Iván Pérez de Pedro
Lucía Valiente de Santis
Beatriz Pérez-Villardón
Isabel Piñero-Uribe
Javier Mora-Robles
Víctor Manuel Becerra-Muñoz
Manuel Jiménez-Navarro
author_facet Ana I. Molina-Ramos
Elisabeth Gómez-Moyano
Jorge Rodríguez-Capitán
María Angullo-Gómez
Patricia Gallardo-Jiménez
Iván Pérez de Pedro
Lucía Valiente de Santis
Beatriz Pérez-Villardón
Isabel Piñero-Uribe
Javier Mora-Robles
Víctor Manuel Becerra-Muñoz
Manuel Jiménez-Navarro
author_sort Ana I. Molina-Ramos
collection DOAJ
description The coronavirus disease of 2019 (COVID-19) has been a cause of significant morbidity and mortality worldwide. Among the short- and long-term consequences of COVID-19, myocarditis is a disease to be taken into consideration. Myocarditis, in general, is related to a poor prognosis. However, the epidemiology and prognosis of myocarditis related to COVID-19 are currently unknown. While vaccination against COVID-19 is of great benefit at a public health level, the risk of myocarditis should be considered in the context of the global benefits of vaccination. In this narrative review, we will summarize the etiopathogenic bases, the epidemiology, the clinical manifestations, the course, diagnosis, prognosis, and the treatment of myocarditis related to SARS-CoV-2, as well as myocarditis secondary to mRNA vaccines.
first_indexed 2024-03-09T17:43:32Z
format Article
id doaj.art-60998c88192146cf91389365af855300
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T17:43:32Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-60998c88192146cf91389365af8553002023-11-24T11:21:13ZengMDPI AGJournal of Clinical Medicine2077-03832022-11-011123699910.3390/jcm11236999Myocarditis Related to COVID-19 and SARS-CoV-2 VaccinationAna I. Molina-Ramos0Elisabeth Gómez-Moyano1Jorge Rodríguez-Capitán2María Angullo-Gómez3Patricia Gallardo-Jiménez4Iván Pérez de Pedro5Lucía Valiente de Santis6Beatriz Pérez-Villardón7Isabel Piñero-Uribe8Javier Mora-Robles9Víctor Manuel Becerra-Muñoz10Manuel Jiménez-Navarro11Centro de Investigación en Red de Enfermedades Cardiovasculares (CIBERCV), Cardiology Department, Hospital Universitario Virgen de la Victoria, 29010 Málaga, SpainDermatology Department, Hospital Regional Universitario de Málaga, 29010 Málaga, SpainCentro de Investigación en Red de Enfermedades Cardiovasculares (CIBERCV), Cardiology Department, Hospital Universitario Virgen de la Victoria, 29010 Málaga, SpainCentro de Investigación en Red de Enfermedades Cardiovasculares (CIBERCV), Cardiology Department, Hospital Universitario Virgen de la Victoria, 29010 Málaga, SpainInternal Medicine Department, Hospital Regional Universitario de Málaga, 29010 Málaga, SpainInternal Medicine Department, Hospital Regional Universitario de Málaga, 29010 Málaga, SpainInfectious Diseases Department, Hospital Regional Universitario de Málaga, 29010 Málaga, SpainCardiology Department, Hospital Regional Universitario de Málaga, 29010 Málaga, SpainCardiology Department, Hospital Regional Universitario de Málaga, 29010 Málaga, SpainCardiology Department, Hospital Regional Universitario de Málaga, 29010 Málaga, SpainCentro de Investigación en Red de Enfermedades Cardiovasculares (CIBERCV), Cardiology Department, Hospital Universitario Virgen de la Victoria, 29010 Málaga, SpainCentro de Investigación en Red de Enfermedades Cardiovasculares (CIBERCV), Cardiology Department, Hospital Universitario Virgen de la Victoria, 29010 Málaga, SpainThe coronavirus disease of 2019 (COVID-19) has been a cause of significant morbidity and mortality worldwide. Among the short- and long-term consequences of COVID-19, myocarditis is a disease to be taken into consideration. Myocarditis, in general, is related to a poor prognosis. However, the epidemiology and prognosis of myocarditis related to COVID-19 are currently unknown. While vaccination against COVID-19 is of great benefit at a public health level, the risk of myocarditis should be considered in the context of the global benefits of vaccination. In this narrative review, we will summarize the etiopathogenic bases, the epidemiology, the clinical manifestations, the course, diagnosis, prognosis, and the treatment of myocarditis related to SARS-CoV-2, as well as myocarditis secondary to mRNA vaccines.https://www.mdpi.com/2077-0383/11/23/6999COVID-19myocarditismRNA vaccines
spellingShingle Ana I. Molina-Ramos
Elisabeth Gómez-Moyano
Jorge Rodríguez-Capitán
María Angullo-Gómez
Patricia Gallardo-Jiménez
Iván Pérez de Pedro
Lucía Valiente de Santis
Beatriz Pérez-Villardón
Isabel Piñero-Uribe
Javier Mora-Robles
Víctor Manuel Becerra-Muñoz
Manuel Jiménez-Navarro
Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination
Journal of Clinical Medicine
COVID-19
myocarditis
mRNA vaccines
title Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination
title_full Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination
title_fullStr Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination
title_full_unstemmed Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination
title_short Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination
title_sort myocarditis related to covid 19 and sars cov 2 vaccination
topic COVID-19
myocarditis
mRNA vaccines
url https://www.mdpi.com/2077-0383/11/23/6999
work_keys_str_mv AT anaimolinaramos myocarditisrelatedtocovid19andsarscov2vaccination
AT elisabethgomezmoyano myocarditisrelatedtocovid19andsarscov2vaccination
AT jorgerodriguezcapitan myocarditisrelatedtocovid19andsarscov2vaccination
AT mariaangullogomez myocarditisrelatedtocovid19andsarscov2vaccination
AT patriciagallardojimenez myocarditisrelatedtocovid19andsarscov2vaccination
AT ivanperezdepedro myocarditisrelatedtocovid19andsarscov2vaccination
AT luciavalientedesantis myocarditisrelatedtocovid19andsarscov2vaccination
AT beatrizperezvillardon myocarditisrelatedtocovid19andsarscov2vaccination
AT isabelpinerouribe myocarditisrelatedtocovid19andsarscov2vaccination
AT javiermorarobles myocarditisrelatedtocovid19andsarscov2vaccination
AT victormanuelbecerramunoz myocarditisrelatedtocovid19andsarscov2vaccination
AT manueljimeneznavarro myocarditisrelatedtocovid19andsarscov2vaccination